Related Experiment Videos
Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells
D L Hudson1, M O'Hare, F M Watt
1Institute of Urology and Nephrology, Research Laboratories, Department of Surgery, University College London Medical School, University of London, United Kingdom. d.hudson@ucl.ac.uk
Summary
Researchers identified two colony types in human prostate cells. Type II colonies, derived from stem cells, formed prostate structures, suggesting their role in prostate epithelial regeneration.
Area of Science:
- Urology
- Cell Biology
- Stem Cell Research
Background:
- Prostate epithelial stem cells are crucial for tissue homeostasis and regeneration.
- Identifying and characterizing these stem cells is essential for understanding prostate cancer and developing therapies.
Purpose of the Study:
- To identify and characterize stem cells within human prostate epithelial cell populations.
- To distinguish between stem cell progeny and differentiated cells based on colony morphology and behavior.
Main Methods:
- Clonal analysis of freshly isolated human prostate epithelial cells.
- Culture of cells in two-dimensional and three-dimensional (Matrigel) systems.
- Morphological assessment of colony types (Type I and Type II).
- Analysis of cell differentiation markers, including the androgen receptor.
Main Results:
- Two distinct colony types were observed: Type I (small, irregular, mixed cell types) and Type II (large, round, homogeneous, undifferentiated, dividing cells).
- Colony-forming efficiency was 5.8% +/- 1.8%.
- Type II colonies, comprising approximately 1 in 200 plated cells, formed structures resembling prostate epithelium in Matrigel culture, with luminal cells expressing androgen receptors.
Conclusions:
- Type II colonies exhibit characteristics consistent with prostate stem cell progeny due to their proliferative potential and ability to differentiate.
- Type I colonies likely represent a more differentiated transit-amplifying cell population.
- These findings provide insights into prostate epithelial stem cell biology and potential therapeutic targets.